
Explore cutting-edge insights from DERM 2025, focusing on innovative treatments and emerging research in dermatology for improved patient care.

Explore cutting-edge insights from DERM 2025, focusing on innovative treatments and emerging research in dermatology for improved patient care.

Discover the latest in regenerative aesthetics and body contouring at DERM 2025, featuring insights from Suneel Chilukuri, MD, on skin care trends and biohacking.

Lisa Swanson, MD, FAAD, shares innovative insights on pediatric dermatology, emphasizing effective treatments and communication strategies for young patients at DERM 2025.

April Martinez-Dulay, MSN, APRN, FNP-BC, shares insights on diagnosing and treating types of dermatitis at DERM 2025, emphasizing innovative approaches and patient care strategies.

James Song, MD, FAAD, reveals insights on abrocitinib's safety in atopic dermatitis, highlighting lower conjunctivitis rates compared to dupilumab at DERM 2025.

At DERM 2025, David Cotter, MD, PhD, shared how GEP testing revolutionizes skin cancer management and enhances patient care at the forefront of dermatology innovation.

Dermatology has the opportunity of directing and leading AI use in the field, according to David Cotter, MD, PhD.

Tips for leveraging the right topical to improve patient outcomes from Linda Stein Gold, MD.

Adam Friedman, MD, shares tips for recognizing and addressing tinea at the DERM 2025 conference.

DERM 2025 featured tips and tricks for a thorough pruritus diagnosis and treatment strategy from Adam Friedman, MD.

Lisa Swanson, MD, discusses the unmet needs in pediatric dermatology at the DERM 2025 conference.

Hure details what clinicians need to know to protect their patients.

Joe Gorelick, MSN, FNP-C, discusses data on systemic treatments for atopic dermatitis presented at the Derm 2025 conference.

The DERM 2025 midway recap includes tips for atopic dermatitis, chronic hand eczema, and pruritus.

Rheumatologist Karim Ladak, MD, shared diagnostic and treatment tips for cutaneous lupus at DERM 2025.

Psoriasis in high impact areas responded well to icotrokinra, presenting a potential exciting option for patients.

At the DERM 2025 conference, Scott Boswell, MD, shares tips for combining therapies.

James Song, MD, discussed his UnlIMMited DERM 2025 poster detailing risankizumab's efficacy for genital and scalp psoriasis.

Joe Gorelick, MSN, FNP-C, discusses upcoming highlights and new data expected at the upcoming DERM 2025 CME Conference.